thalidomide has been researched along with sulfur hexafluoride in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bertolotto, M; Cova, MA; Crocè, LS; Gasparini, C; Nascimben, F; Pozzato, G; Tiribelli, C | 1 |
| Cao, L; Han, F; Li, A; Liu, M; Zheng, W; Zhou, J | 1 |
| Cao, LH; Han, F; Li, AH; Liu, JB; Liu, M; Luo, RZ; Zheng, W; Zhou, JH | 1 |
| Cao, LH; Han, F; Li, AH; Liu, M; Luo, RZ; Wu, PH; Zheng, W; Zhou, JH | 1 |
4 other study(ies) available for thalidomide and sulfur hexafluoride
| Article | Year |
|---|---|
Blood flow changes in hepatocellular carcinoma after the administration of thalidomide assessed by reperfusion kinetics during microbubble infusion: preliminary results.
Topics: Aged; Angiogenesis Inhibitors; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Male; Microbubbles; Middle Aged; Neovascularization, Pathologic; Phospholipids; Statistics, Nonparametric; Sulfur Hexafluoride; Survival Analysis; Thalidomide; Treatment Outcome; Ultrasonography, Interventional | 2006 |
Antiangiogenic tumor treatment: noninvasive monitoring with contrast pulse sequence imaging for contrast-enhanced grayscale ultrasound.
Topics: Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Contrast Media; Image Enhancement; Image Interpretation, Computer-Assisted; Information Storage and Retrieval; Liver Neoplasms, Experimental; Mice; Phospholipids; Prognosis; Reproducibility of Results; Sensitivity and Specificity; Signal Processing, Computer-Assisted; Sulfur Hexafluoride; Thalidomide; Treatment Outcome; Ultrasonography | 2010 |
Quantitative assessment of tumor blood flow in mice after treatment with different doses of an antiangiogenic agent with contrast-enhanced destruction-replenishment US.
Topics: Analysis of Variance; Angiogenesis Inhibitors; Animals; Carboxymethylcellulose Sodium; Carcinoma, Hepatocellular; Cell Line, Tumor; Contrast Media; Liver Neoplasms, Experimental; Mice; Neovascularization, Pathologic; Random Allocation; Statistics, Nonparametric; Sulfur Hexafluoride; Thalidomide; Ultrasonography | 2011 |
Contrast-enhanced ultrasonic parametric perfusion imaging in the evaluation of antiangiogenic tumor treatment.
Topics: Angiogenesis Inhibitors; Animals; Area Under Curve; Carcinoma, Hepatocellular; Contrast Media; Disease Models, Animal; Immunohistochemistry; Liver Neoplasms; Mice; Microcirculation; Phospholipids; Sulfur Hexafluoride; Thalidomide; Ultrasonography | 2012 |